Does CABAZITAXEL Cause Dyspnoea? 113 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Dyspnoea have been filed in association with CABAZITAXEL (Jevtana). This represents 4.4% of all adverse event reports for CABAZITAXEL.
113
Reports of Dyspnoea with CABAZITAXEL
4.4%
of all CABAZITAXEL reports
42
Deaths
49
Hospitalizations
How Dangerous Is Dyspnoea From CABAZITAXEL?
Of the 113 reports, 42 (37.2%) resulted in death, 49 (43.4%) required hospitalization, and 14 (12.4%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABAZITAXEL. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which CABAZITAXEL Alternatives Have Lower Dyspnoea Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE